vs
AMERISERV FINANCIAL INC（ASRV）与波士顿科学（MLSS）财务数据对比。点击上方公司名可切换其他公司
AMERISERV FINANCIAL INC的季度营收约是波士顿科学的1.9倍（$3.9M vs $2.1M），AMERISERV FINANCIAL INC净利率更高（36.9% vs -53.0%，领先89.9%），AMERISERV FINANCIAL INC同比增速更快（2.4% vs 2.2%），过去两年波士顿科学的营收复合增速更高（-4.3% vs -46.6%）
Ameriserv Financial Inc.是总部位于美国宾夕法尼亚州的区域金融服务控股公司，主要为当地个人消费者及中小企业提供零售与商业银行业务，包括存款、各类贷款及财富管理解决方案。
波士顿科学公司是源自美国的跨国生物医疗企业，专业研发生产介入医疗领域医疗器械，产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
ASRV vs MLSS — 直观对比
营收规模更大
ASRV
是对方的1.9倍
$2.1M
营收增速更快
ASRV
高出0.2%
2.2%
净利率更高
ASRV
高出89.9%
-53.0%
两年增速更快
MLSS
近两年复合增速
-46.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.9M | $2.1M |
| 净利润 | $1.4M | $-1.1M |
| 毛利率 | — | 73.0% |
| 营业利润率 | 43.0% | -52.5% |
| 净利率 | 36.9% | -53.0% |
| 营收同比 | 2.4% | 2.2% |
| 净利润同比 | 62.2% | 46.4% |
| 每股收益（稀释后） | $0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRVMLSS
| Q4 25 | $3.9M | $2.1M | ||
| Q3 25 | $15.4M | $2.4M | ||
| Q2 25 | $14.5M | $2.3M | ||
| Q1 25 | $14.1M | $2.2M | ||
| Q4 24 | $3.8M | $2.0M | ||
| Q3 24 | $13.1M | $2.5M | ||
| Q2 24 | $13.2M | $1.9M | ||
| Q1 24 | $13.7M | $2.2M |
净利润ASRVMLSS
| Q4 25 | $1.4M | $-1.1M | ||
| Q3 25 | $2.5M | $-1.2M | ||
| Q2 25 | $-282.0K | $-1.5M | ||
| Q1 25 | $1.9M | $-2.0M | ||
| Q4 24 | $889.0K | $-2.0M | ||
| Q3 24 | $1.2M | $-1.5M | ||
| Q2 24 | $-375.0K | $223.6K | ||
| Q1 24 | $1.9M | $-1.4M |
毛利率ASRVMLSS
| Q4 25 | — | 73.0% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 69.6% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | 75.0% | ||
| Q3 24 | — | 73.0% | ||
| Q2 24 | — | 76.1% | ||
| Q1 24 | — | 74.5% |
营业利润率ASRVMLSS
| Q4 25 | 43.0% | -52.5% | ||
| Q3 25 | 20.0% | -48.1% | ||
| Q2 25 | -2.4% | -63.9% | ||
| Q1 25 | 17.0% | -89.5% | ||
| Q4 24 | 28.2% | -101.4% | ||
| Q3 24 | 10.8% | -58.4% | ||
| Q2 24 | -3.7% | -96.0% | ||
| Q1 24 | 17.4% | -65.1% |
净利率ASRVMLSS
| Q4 25 | 36.9% | -53.0% | ||
| Q3 25 | 16.5% | -48.9% | ||
| Q2 25 | -1.9% | -63.8% | ||
| Q1 25 | 13.6% | -89.3% | ||
| Q4 24 | 23.3% | -101.1% | ||
| Q3 24 | 9.0% | -58.1% | ||
| Q2 24 | -2.8% | 12.1% | ||
| Q1 24 | 13.9% | -64.1% |
每股收益（稀释后）ASRVMLSS
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.15 | $-0.01 | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $0.12 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.07 | $-0.02 | ||
| Q2 24 | $-0.02 | — | ||
| Q1 24 | $0.11 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $119.3M | $2.8M |
| 总资产 | $1.5B | $7.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRVMLSS
| Q4 25 | — | $1.1M | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $5.0M |
股东权益ASRVMLSS
| Q4 25 | $119.3M | $2.8M | ||
| Q3 25 | $114.6M | $2.5M | ||
| Q2 25 | $110.9M | $3.3M | ||
| Q1 25 | $110.8M | $4.5M | ||
| Q4 24 | $107.2M | $5.8M | ||
| Q3 24 | $108.2M | $7.2M | ||
| Q2 24 | $103.7M | $8.0M | ||
| Q1 24 | $103.9M | $7.5M |
总资产ASRVMLSS
| Q4 25 | $1.5B | $7.8M | ||
| Q3 25 | $1.5B | $8.5M | ||
| Q2 25 | $1.4B | $8.1M | ||
| Q1 25 | $1.4B | $9.1M | ||
| Q4 24 | $1.4B | $9.8M | ||
| Q3 24 | $1.4B | $11.2M | ||
| Q2 24 | $1.4B | $12.0M | ||
| Q1 24 | $1.4B | $11.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-226.1K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.21× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRVMLSS
| Q4 25 | $3.2M | $-226.1K | ||
| Q3 25 | $1.4M | $81.8K | ||
| Q2 25 | $-62.0K | $-1.8M | ||
| Q1 25 | $599.0K | $-1.0M | ||
| Q4 24 | $2.7M | $-1.5M | ||
| Q3 24 | $-235.0K | $-973.9K | ||
| Q2 24 | $1.7M | $783.7K | ||
| Q1 24 | $-2.2M | $-1.2M |
现金转化率ASRVMLSS
| Q4 25 | 2.21× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.02× | — | ||
| Q3 24 | -0.20× | — | ||
| Q2 24 | — | 3.50× | ||
| Q1 24 | -1.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRV
| Asset Management1 | $3.1M | 79% |
| Other | $838.0K | 21% |
MLSS
暂无分部数据
